acq	kodak buys stake enzon enzn eastman kodak acquired pct equity interest enzon inc pharmaceutical company specializing protein therapy kodak secured worldwide marketing rights for enzon peg enzymes used treatment oxygen toxicity disorders hyperuricemia and gout company acquired two mln enzon shares for mln dlrs loans enzon two mln dlrs and interest dlrs credited purchase price kodak drugs covered marketing rights initial stages food and drug administration approval process investment provide capital complete fda review process and provide marketing outlet for drugs drugs peg superoxide disdmutase and peg catalase for use oxygen toxicity disorders that fatal tissue damage associated severe burns organ transplants heart attacks and trauma and peg uricase for treatment gout and conditions caused buildup high levels uric acid body InformationRetrieval.reuter